Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-10-21 Sale | 2025-10-23 4:20 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 10,000 | $28.03 | $280,300 | 404,235 (Indirect Direct) | View |
| 2025-10-16 Sale | 2025-10-17 4:15 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $25.22 | $126,100 | 173,866 (Indirect Direct) | View |
| 2025-10-10 Sale | 2025-10-15 8:12 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 31,092 | $23.72 | $737,536 | 162,230 (Indirect Direct) | View |
| 2025-09-30 Sale | 2025-10-02 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 31,092 | $22.58 | $702,057 | 192,372 (Indirect Direct) | View |
| 2025-09-19 Sale | 2025-09-19 9:17 pm | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 31,092 | $22.95 | $713,561 | 227,301 (Indirect Direct) | View |
| 2025-09-16 Sale | 2025-09-18 4:01 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $24.34 | $121,700 | 178,866 (Indirect Direct) | View |
| 2025-09-15 Sale | 2025-09-17 8:08 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 189 | $24.19 | $4,572 | 53,468 (Direct) | View |
| 2025-09-10 Sale | 2025-09-12 4:01 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 20,000 | $26.17 | $523,400 | 183,866 (Indirect Direct) | View |
| 2025-09-08 Sale | 2025-09-10 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 42,729 | $27.85 | $1,190,130 | 414,235 (Indirect Direct) | View |
| 2025-09-02 Sale | 2025-09-03 1:06 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 548 | $28.08 | $15,386 | 53,657 (Direct) | View |
| 2025-08-27 Sale | 2025-08-29 4:19 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 225,000 | $28.23 | $6,352,743 | 1,646,027 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 4:40 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $27.8 | $139,000 | 203,866 (Indirect Direct) | View |
| 2025-07-17 Sale | 2025-07-18 4:02 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 19,725 | $20.21 | $398,735 | 1,971,565 (Indirect Direct) | View |
| 2025-07-16 Sale | 2025-07-18 4:00 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $19.55 | $97,750 | 208,866 (Indirect Direct) | View |
| 2025-07-14 Sale | 2025-07-16 4:11 pm | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 139,365 | $20.19 | $2,813,091 | 2,101,625 (Indirect Direct) | View |
| 2025-06-16 Sale | 2025-06-18 08:49 am | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,000 | $18.77 | $93,850 | 213,866 (Indirect Direct) | View |
| 2025-03-17 Sale | 2025-03-18 12:27 pm | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 183 | $24.82 | $4,543 | 47,955 (Direct) | View |
| 2025-03-05 Sale | 2025-03-06 5:17 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 5,569 | $25.1 | $139,789 | 218,866 (Indirect Direct) | View |
| 2025-02-11 Sale | 2025-02-12 1:59 pm | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 363 | $28.54 | $10,360 | 83,945 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:20 pm | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 695 | $29.52 | $20,519 | 224,435 (Indirect Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:18 pm | Apellis Pharmaceuticals Inc. | APLS | Townsend Adam J. Chief Commercial Officer | 695 | $29.52 | $20,519 | 84,050 (Direct) | View |
| 2025-01-29 Sale | 2025-01-30 12:15 pm | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 546 | $29.52 | $16,120 | 199,061 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-21 Exercise | 2025-10-23 4:20 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 10,000 | $0 | 404,235 (Direct) | View |
| 2025-10-21 Exercise | 2025-10-23 4:20 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 10,000 | $10.03 | 404,235 (Direct) | View |
| 2025-06-24 Other | 2025-10-15 8:12 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 8,624 | $0 | 162,230 (Direct) | View |
| 2025-09-30 Other | 2025-10-02 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 3,837 | $0 | 192,372 (Indirect) | View |
| 2025-09-19 Other | 2025-09-19 9:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director | 3,837 | $0 | 227,301 (Indirect) | View |
| 2025-09-08 Exercise | 2025-09-10 4:02 pm | N/A 2027-10-18 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 15,000 | $0 | 414,235 (Direct) | View |
| 2025-09-08 Exercise | 2025-09-10 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 15,000 | $10.03 | 414,235 (Direct) | View |
| 2025-09-02 Option Award | 2025-09-03 11:55 am | N/A 2035-09-02 | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 76,242 | $0 | 143,424 (Direct) | View |
| 2025-08-26 Option Award | 2025-09-02 10:13 am | N/A 2035-08-26 | Apellis Pharmaceuticals Inc. | APLS | MELTZER LESLIE Chief Research and Development | 154,396 | $0 | 154,396 (Direct) | View |
| 2025-07-17 Exercise | 2025-07-18 4:02 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 8,997 | $0 | 1,971,565 (Direct) | View |
| 2025-07-17 Exercise | 2025-07-18 4:02 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 8,997 | $4.31 | 1,971,565 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 4:11 pm | N/A 2027-08-20 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 66,003 | $0 | 2,101,625 (Direct) | View |
| 2025-07-14 Exercise | 2025-07-16 4:11 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 66,003 | $4.31 | 2,101,625 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:09 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 6,250 | $0 | 54,205 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:27 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 67,396 | $19.39 | 134,578 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:27 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 45,095 | $0 | 134,578 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:25 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:24 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Nicholson Nur Chief Technical Officer | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:21 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Francois Cedric Chief Executive Officer | 287,500 | $19.39 | 287,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:20 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Sullivan Timothy Eugene Chief Financial Officer | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:19 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:16 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Baumal Caroline Chief Medical Officer | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:15 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | Chopas James George VP/Chief Accounting Officer | 11,250 | $19.39 | 11,250 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-11 4:10 pm | N/A 2035-06-09 | Apellis Pharmaceuticals Inc. | APLS | DeLong Mark Jeffrey Chief Business & Strat Officer | 82,500 | $19.39 | 82,500 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 11:46 am | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 22,087 | $0 | 55,063 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 11:46 am | N/A 2035-05-28 | Apellis Pharmaceuticals Inc. | APLS | Boucher Kelley Chief People Officer | 32,976 | $16.8 | 55,063 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-22 1:19 pm | N/A 2026-02-06 | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,780 | $0 | 1,160,496 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-22 1:19 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Deschatelets Pascal Chief Scientific Officer | 12,780 | $3.76 | 1,160,496 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:23 pm | N/A 2032-04-17 | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 28,195 | $18.2 | 44,678 (Direct) | View |
| 2025-04-17 Option Award | 2025-04-21 4:23 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | WHEELER CRAIG A Director | 16,483 | $0 | 44,678 (Direct) | View |
| 2025-03-04 Gift | 2025-03-06 5:17 pm | N/A N/A | Apellis Pharmaceuticals Inc. | APLS | Watson David O. General Counsel | 6,667 | $0 | 218,866 (Indirect) | View |